{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:59:47Z","timestamp":1788872387842,"version":"build-2803163510"},"reference-count":50,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Grant-in-Aid of Research, Artistry, and Scholarship"},{"name":"University of Minnesota, Office of the Vice President for Research"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.taap.2013.08.012","type":"journal-article","created":{"date-parts":[[2013,8,28]],"date-time":"2013-08-28T01:02:59Z","timestamp":1377651779000},"page":"47-57","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Differential cardiotoxicity in response to chronic doxorubicin treatment in male spontaneous hypertension-heart failure (SHHF), spontaneously hypertensive (SHR), and Wistar Kyoto (WKY) rats"],"prefix":"10.1016","volume":"273","author":[{"given":"Leslie C.","family":"Sharkey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Judith","family":"Radin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lois","family":"Heller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynette K.","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Tobias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilze","family":"Matise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred S.","family":"Apple","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia A.","family":"McCune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2013.08.012_bb0005","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1373\/clinchem.2007.097568","article-title":"Analytical characteristics of commercial cardiac troponin I and T immunoassays in serum from rats, dogs, and monkeys with induced acute myocardial injury","volume":"54","author":"Apple","year":"2008","journal-title":"Clin. Chem."},{"key":"10.1016\/j.taap.2013.08.012_bb0010","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1016\/S0024-3205(01)01241-3","article-title":"L-NAME prevents in vivo the inactivation but not the downregulation of hepatic cytochrome P450 caused by an acute inflammatory reaction","volume":"69","author":"Barakat","year":"2001","journal-title":"Life Sci."},{"key":"10.1016\/j.taap.2013.08.012_bb0015","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1006\/jmcc.1999.0972","article-title":"Persistent effects of doxorubicin on cardiac gene expression","volume":"31","author":"Boucek","year":"1999","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.taap.2013.08.012_bb0020","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s12012-011-9103-5","article-title":"Merits of non-invasive rat models of left ventricular heart failure","volume":"11","author":"Carll","year":"2011","journal-title":"Cardiovasc. Toxicol."},{"key":"10.1016\/j.taap.2013.08.012_bb0025","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1139\/y99-133","article-title":"Doxorubicin-induced late cardiotoxicity: delayed impairment of Ca2+-handling mechanisms in the sarcoplasmic reticulum in the rat","volume":"78","author":"Chugun","year":"2000","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.taap.2013.08.012_bb0030","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/00005344-200001000-00013","article-title":"Comparison of doxorubicin- and MEN 10755-induced long-term progressive cardiotoxicity in the rat","volume":"35","author":"Cirillo","year":"2000","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.taap.2013.08.012_bb0035","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1161\/HYPERTENSIONAHA.107.102160","article-title":"Altered soluble epoxide hydrolase gene expression and function and vascular disease risk in the stroke-prone spontaneously hypertensive rat","volume":"51","author":"Corenblum","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.taap.2013.08.012_bb0040","first-page":"598","article-title":"Inhibition of soluble epoxide hydrolase reduces food intake and increases metabolic rate in obese mice","volume":"22","author":"do Campo","year":"2010","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"10.1016\/j.taap.2013.08.012_bb0045","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1161\/01.HYP.0000032278.75806.68","article-title":"Polymorphisms in soluble epoxide hydrolase and blood pressure in spontaneously hypertensive rats","volume":"40","author":"Fornage","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.taap.2013.08.012_bb0050","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1093\/annonc\/mdj034","article-title":"Long-term cardiac toxicity after adjuvant epirubicin-based chemotherapy in early breast cancer: French adjuvant study group results","volume":"17","author":"Fumoleau","year":"2006","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.taap.2013.08.012_bb0055","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1200\/JCO.2007.14.2851","article-title":"Implementing a survivorship care plan for patients with breast cancer","volume":"26","author":"Ganz","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.taap.2013.08.012_bb0060","series-title":"Eicosanoids. Presented at LIPID MAPS Lipidomics Workshop, April 28, 2007","author":"Harkewicz","year":"2007"},{"key":"10.1016\/j.taap.2013.08.012_bb0065","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1093\/toxsci\/kfp092","article-title":"Continuous electrocardiogram reveals differences in the short-term cardiotoxic response of Wistar-Kyoto and spontaneously hypertensive rats to doxorubicin","volume":"110","author":"Hazari","year":"2009","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.taap.2013.08.012_bb0070","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/0041-008X(85)90284-4","article-title":"Comparison of the severity of the chronic cardiotoxicity produced by doxorubicin in normotensive and hypertensive rats","volume":"78","author":"Herman","year":"1985","journal-title":"Toxicol. Appl. Physiol."},{"key":"10.1016\/j.taap.2013.08.012_bb0075","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/0041-008X(88)90226-8","article-title":"Protective effect of ICRF-187 on doxorubicin-induced cardiac and renal toxicity in spontaneously hypertensive (SHR) and normotensive (WKY) rats","volume":"92","author":"Herman","year":"1988","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2013.08.012_bb0080","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0300-483X(98)00049-3","article-title":"Comparison of the chronic toxicity of piroxantrone, losoxantrone and doxorubicin in spontaneously hypertensive rats","volume":"128","author":"Herman","year":"1998","journal-title":"Toxicology"},{"key":"10.1016\/j.taap.2013.08.012_bb0085","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1200\/JCO.1999.17.7.2237","article-title":"Correlation between serum levels of cardiac troponin-T and the severity of the chronic cardiomyopathy induced by doxorubicin","volume":"17","author":"Herman","year":"1999","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.taap.2013.08.012_bb0090","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0022-3565(24)38740-3","article-title":"Synthesis of 5-oxo-6,8,11,14-eicosatetaenoic acid and identification of novel omega-oxidized metabolites in the mouse macrophage","volume":"296","author":"Hevko","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.taap.2013.08.012_bb9000","doi-asserted-by":"crossref","first-page":"H1775","DOI":"10.1152\/ajpheart.00305.2002","article-title":"Structural, functional, and molecular characterization of the SHHF model of heart failure","volume":"283","author":"Heyen","year":"2002","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.taap.2013.08.012_bb0095","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1200\/JCO.2006.09.7451","article-title":"Noninvasive evaluation of late anthracycline cardiac toxicity in childhood cancer survivors","volume":"25","author":"Hudson","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.taap.2013.08.012_bb0100","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1152\/physrev.00021.2011","article-title":"Epoxides and soluble epoxide hydrolase in cardiovascular physiology","volume":"92","author":"Imig","year":"2012","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.taap.2013.08.012_bb0105","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1002\/pbc.21695","article-title":"Renal late effects in patients treated for cancer in childhood: a report from the children's oncology group. Pediatr","volume":"51","author":"Jones","year":"2008","journal-title":"Blood Cancer"},{"key":"10.1016\/j.taap.2013.08.012_bb0110","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1600-6143.2012.04317.x","article-title":"Cardiac troponin T before and after kidney transplantation: determinants and implications for posttransplant survival","volume":"13","author":"Keddis","year":"2013","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.taap.2013.08.012_bb0115","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1253\/circj.68.163","article-title":"Troponin-T and brain natriuretic peptide as predictors for adriamycin-induced cardiomyopathy in rats","volume":"68","author":"Koh","year":"2004","journal-title":"Circ. J."},{"key":"10.1016\/j.taap.2013.08.012_bb0120","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1634\/theoncologist.2008-0104","article-title":"Cancer survivorship: a pediatric perspective","volume":"13","author":"Landier","year":"2008","journal-title":"Oncologist"},{"key":"10.1016\/j.taap.2013.08.012_bb0125","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1161\/01.CIR.0000093196.59829.DF","article-title":"Time-dependent and tissue-specific accumulation of mtDNA and respiratory chain defects in chronic doxorubicin cardiomyopathy","volume":"108","author":"Lebrecht","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.taap.2013.08.012_bb0130","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1093\/ndt\/gfg564","article-title":"Mitochondrial DNA and its respiratory chain products are defective in doxorubicin nephrosis","volume":"19","author":"Lebrecht","year":"2004","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.taap.2013.08.012_bb0135","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/ijc.22409","article-title":"The 6-maleimidocaproyl hydrazone derivative of doxorubicin is superior to free doxorubicin with respect to cardiotoxicity and mitochondrial damage","volume":"120","author":"Lebrecht","year":"2006","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.taap.2013.08.012_bb0140","doi-asserted-by":"crossref","first-page":"5050","DOI":"10.1002\/cncr.27493","article-title":"Late effects of chemotherapy and radiotherapy in osteosarcoma and Ewing sarcoma patients","volume":"18","author":"Longhi","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.taap.2013.08.012_bb0145","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1074\/jbc.M608057200","article-title":"Compensatory mechanism for homeostatic blood pressure regulation in Ephx2 gene-disrupted mice","volume":"282","author":"Luria","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.taap.2013.08.012_bb0155","series-title":"Mechanisms of Heart Failure","first-page":"91","article-title":"SHHF\/Mcc-facp rat model: a genetic model of congestive heart failure","author":"McCune","year":"1995"},{"key":"10.1016\/j.taap.2013.08.012_bb0160","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1124\/pr.56.2.6","article-title":"Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity","volume":"56","author":"Minotti","year":"2004","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.taap.2013.08.012_bb0165","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/ng.129","article-title":"Soluble epoxide hydrolase is a susceptibility factor for heart failure in a rat model of human disease","volume":"40","author":"Monti","year":"2008","journal-title":"Nat. Genet."},{"key":"10.1016\/j.taap.2013.08.012_bb0170","doi-asserted-by":"crossref","first-page":"b4606","DOI":"10.1136\/bmj.b4606","article-title":"Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort","volume":"339","author":"Mulrooney","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.taap.2013.08.012_bb0175","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1124\/jpet.111.186031","article-title":"A selective cysteinyl leukotriene receptor 2 antagonist blocks myocardial ischemia\/reperfusion injury and vascular permeability in mice","volume":"339","author":"Ni","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.taap.2013.08.012_bb0180","first-page":"1213","article-title":"Doxorubicin-induced cardiomyopathy: from molecular mechanisms to therapeutic strategies","volume":"52","author":"Octavia","year":"2012","journal-title":"J. Mol. Cell Biol."},{"key":"10.1016\/j.taap.2013.08.012_bb0185","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1755-5922.2010.00150.x","article-title":"Soluble epoxide hydrolase inhibitors and heart failure","volume":"29","author":"Qiu","year":"2011","journal-title":"Cardiovasc. Ther."},{"key":"10.1016\/j.taap.2013.08.012_bb0190","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1097\/MPH.0b013e3181580ea2","article-title":"Late echocardiography assessment of systolic and diastolic function of the left ventricle in pediatric cancer survivors after anthracycline therapy","volume":"29","author":"Santin","year":"2007","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"10.1016\/j.taap.2013.08.012_bb0195","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1096\/fj.04-3128fje","article-title":"Novel mechanism of brain soluble epoxide hydrolase-mediated blood pressure regulation in the spontaneously hypertensive rat","volume":"6","author":"Sellers","year":"2005","journal-title":"FASEB"},{"key":"10.1016\/j.taap.2013.08.012_bb0200","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1159\/000312669","article-title":"Cysteinyl leukotrienes and their receptors: molecular and functional characteristics","volume":"85","author":"Singh","year":"2010","journal-title":"Pharmacology"},{"key":"10.1016\/j.taap.2013.08.012_bb0205","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1186\/1471-2407-10-337","article-title":"Cardiotoxicity of anthracycline agents for the treatment of cancer: systematic review and meta-analysis of randomized controlled trials","volume":"10","author":"Smith","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1016\/j.taap.2013.08.012_bb0210","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1001\/jama.1991.03470120074036","article-title":"Cardiac toxicity 4\u201320years after completing anthracycline therapy","volume":"266","author":"Steinherz","year":"1991","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.taap.2013.08.012_bb0215","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S1388-9842(00)00111-2","article-title":"Progressive cardiac dysfunction in adriamycin-induced cardiomyopathy rats","volume":"2","author":"Teraoka","year":"2000","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.taap.2013.08.012_bb0220","doi-asserted-by":"crossref","first-page":"214","DOI":"10.2174\/157340311799960645","article-title":"Anthracycline cardiotoxicity: prevalence, pathogenesis and treatment","volume":"7","author":"Volkova","year":"2011","journal-title":"Curr. Cardiol. Rev."},{"key":"10.1016\/j.taap.2013.08.012_bb0225","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s11883-010-0108-5","article-title":"Soluble epoxide hydrolase in atherosclerosis","volume":"12","author":"Wang","year":"2010","journal-title":"Curr. Atheroscler. Rep."},{"key":"10.1016\/j.taap.2013.08.012_bb0230","doi-asserted-by":"crossref","first-page":"23082","DOI":"10.1074\/jbc.M001464200","article-title":"Biochemical evidence for the involvement of tyrosine in epoxide activation during the catalytic cycle of epoxide hydrolase","volume":"275","author":"Yamada","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.taap.2013.08.012_bb0235","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1006\/jmcc.1996.0186","article-title":"Doxorubicin-induced apoptosis in spontaneously hypertensive rats: differential effects in heart, kidney, and intestine, and inhibition by ICRF-187","volume":"28","author":"Zhang","year":"1996","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.taap.2013.08.012_bb0240","doi-asserted-by":"crossref","first-page":"H37","DOI":"10.1152\/ajpheart.00983.2008","article-title":"Overexpression of CYP2J2 provides protection against doxorubicin-induced cardiotoxicity","volume":"297","author":"Zhang","year":"2009","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.taap.2013.08.012_bb0245","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1073\/pnas.0409786102","article-title":"A Mendelian locus on chromosome 16 determines susceptibility to doxorubicin nephropathy in the mouse","volume":"102","author":"Zheng","year":"2005","journal-title":"PNAS"},{"key":"10.1016\/j.taap.2013.08.012_bb0255","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.taap.2009.09.012","article-title":"Acute doxorubicin cardiotoxicity alters cardiac cytochrome P450 expression and arachidonic acid metabolism in rats","volume":"24","author":"Zordoky","year":"2010","journal-title":"Toxicol. Appl. Pharmacol."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X13003621?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X13003621?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T10:14:09Z","timestamp":1746008049000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X13003621"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S0041008X13003621"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2013.08.012","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differential cardiotoxicity in response to chronic doxorubicin treatment in male spontaneous hypertension-heart failure (SHHF), spontaneously hypertensive (SHR), and Wistar Kyoto (WKY) rats","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2013.08.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}